BioMarin Pharmaceutical Inc. (BMRN) Could See Continued Volatility, Baird Reiterates Outperform Rating
Tweet Send to a Friend
Baird analyst Michael Ulz reiterated an Outperform rating and $120.00 price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) after the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
